Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUCE-BP: Amlodipine for Early Hypertension in Pediatric Idiopathic Nephrotic Syndrome
jRCTs031180396Recruiting
- Sponsor
- Clinical Research Fund of Tokyo Metropolitan Government
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of amlodipine in Idiopathic nephrotic syndrome (INS) and hypertension (HTN) (2 arms), sponsored by Clinical Research Fund of Tokyo Metropolitan Government. Primary endpoint: Primary: Blood pressure control without additional antihypertensive treatment at day 28. Started May 2019; status: recruiting.
02
Drugs
amlodipine
03
Conditions
Idiopathic nephrotic syndrome (INS)hypertension (HTN)
Beyond the preview
Go deeper on jRCTs031180396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180396.